Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2010

01-02-2010 | Epidemiology

Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers

Authors: Anouk Pijpe, Peggy Manders, Richard M. Brohet, J. Margriet Collée, Senno Verhoef, Hans F. A. Vasen, Nicoline Hoogerbrugge, Christi J. van Asperen, Charlotte Dommering, Margreet G. E. M. Ausems, Cora M. Aalfs, Encarna B. Gomez-Garcia, Laura J. van‘t Veer, Flora E. van Leeuwen, Matti A. Rookus, HEBON

Published in: Breast Cancer Research and Treatment | Issue 1/2010

Login to get access

Abstract

BRCA1/2 mutation carriers have a high lifetime risk of developing breast cancer. Differences in penetrance indicate that this risk may be influenced by lifestyle factors. Because physical activity is one of the few modifiable risk factors, it may provide a target to add to breast cancer prevention in this high-risk population. We examined the association between self-reported lifetime sports activity and breast cancer risk in a nationwide retrospective cohort study, including 725 carriers, of whom 218 had been diagnosed with breast cancer within 10 years prior to questionnaire completion. We found a nonsignificantly decreased risk for ever engaging in sports activity (HR = 0.84, 95%CI = 0.57–1.24). Among women who had participated in sports, a medium versus low level of intensity and duration (i.e., between 11.0 and 22.7 mean MET hours/week averaged over a lifetime) reduced the risk of breast cancer (HR = 0.59, 95%CI = 0.36–0.95); no dose–response trend was observed. For mean hours/week of sports activity, a nonsignificant trend was observed (HRlow versus never = 0.93, 95%CI = 0.60–1.43; HRmedium versus never = 0.81, 95%CI = 0.51–1.29; HRhigh versus never = 0.78, 95%CI = 0.48–1.29; p trend overall = 0.272; p trend active women = 0.487). For number of years of sports activity no significant associations were found. Among women active in sports before age 30, mean MET hours/week showed the strongest inverse association of all activity measures (HRmedium versus low = 0.60, 95%CI = 0.38–0.96; HRhigh versus low = 0.58, 95%CI = 0.35–0.94; p trend = 0.053). Engaging in sports activity after age 30 was also inversely associated with breast cancer risk (HR = 0.63, 95%CI = 0.44–0.91). Our results indicate that sports activity may reduce the risk of breast cancer in BRCA1/2 mutation carriers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130CrossRefPubMed Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130CrossRefPubMed
2.
go back to reference Chen S, Iversen ES, Friebel T et al (2006) Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 24(6):863–871CrossRefPubMed Chen S, Iversen ES, Friebel T et al (2006) Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 24(6):863–871CrossRefPubMed
3.
go back to reference Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast cancer linkage consortium. Am J Hum Genet 56(1):265–271PubMed Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast cancer linkage consortium. Am J Hum Genet 56(1):265–271PubMed
4.
go back to reference Evans DG, Shenton A, Woodward E, Lalloo F, Howell A, Maher ER (2008) Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a clinical cancer genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family. BMC Cancer 8(1):155CrossRefPubMed Evans DG, Shenton A, Woodward E, Lalloo F, Howell A, Maher ER (2008) Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a clinical cancer genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family. BMC Cancer 8(1):155CrossRefPubMed
5.
go back to reference Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62(3):676–689CrossRefPubMed Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62(3):676–689CrossRefPubMed
6.
go back to reference King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643–646CrossRefPubMed King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643–646CrossRefPubMed
7.
8.
9.
go back to reference Monninkhof EM, Elias SG, Vlems FA et al (2007) Physical activity and breast cancer: a systematic review. Epidemiology 18(1):137–157CrossRefPubMed Monninkhof EM, Elias SG, Vlems FA et al (2007) Physical activity and breast cancer: a systematic review. Epidemiology 18(1):137–157CrossRefPubMed
10.
go back to reference World Cancer Research Fund/American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity, the Prevention of Cancer; A Global Perspective. AICR, Washington, DC, Ref Type: Report World Cancer Research Fund/American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity, the Prevention of Cancer; A Global Perspective. AICR, Washington, DC, Ref Type: Report
11.
go back to reference Lahmann PH, Friedenreich C, Schuit AJ et al (2007) Physical activity and breast cancer risk: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 16(1):36–42CrossRefPubMed Lahmann PH, Friedenreich C, Schuit AJ et al (2007) Physical activity and breast cancer risk: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 16(1):36–42CrossRefPubMed
12.
go back to reference Sprague BL, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA (2008) Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol 168(4):404–411CrossRefPubMed Sprague BL, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA (2008) Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol 168(4):404–411CrossRefPubMed
13.
go back to reference Friedenreich CM, Cust AE (2008) Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 42(8):636–647CrossRefPubMed Friedenreich CM, Cust AE (2008) Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 42(8):636–647CrossRefPubMed
14.
go back to reference Maruti SS, Willett WC, Feskanich D, Rosner B, Colditz GA (2008) A prospective study of age-specific physical activity and premenopausal breast cancer. J Natl Cancer Inst 100(10):728–737CrossRefPubMed Maruti SS, Willett WC, Feskanich D, Rosner B, Colditz GA (2008) A prospective study of age-specific physical activity and premenopausal breast cancer. J Natl Cancer Inst 100(10):728–737CrossRefPubMed
15.
go back to reference Suzuki S, Kojima M, Tokudome S et al (2008) Effect of physical activity on breast cancer risk: findings of the Japan collaborative cohort study. Cancer Epidemiol Biomarkers Prev 17(12):3396–3401CrossRefPubMed Suzuki S, Kojima M, Tokudome S et al (2008) Effect of physical activity on breast cancer risk: findings of the Japan collaborative cohort study. Cancer Epidemiol Biomarkers Prev 17(12):3396–3401CrossRefPubMed
16.
go back to reference Howard RA, Leitzmann MF, Linet MS, Freedman DM (2009) Physical activity and breast cancer risk among pre- and postmenopausal women in the U.S. radiologic technologists cohort. Cancer Causes Control 20(3):323–333CrossRefPubMed Howard RA, Leitzmann MF, Linet MS, Freedman DM (2009) Physical activity and breast cancer risk among pre- and postmenopausal women in the U.S. radiologic technologists cohort. Cancer Causes Control 20(3):323–333CrossRefPubMed
17.
go back to reference Nkondjock A, Robidoux A, Paredes Y, Narod SA, Ghadirian P (2006) Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Res Treat 98(3):285–294CrossRefPubMed Nkondjock A, Robidoux A, Paredes Y, Narod SA, Ghadirian P (2006) Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Res Treat 98(3):285–294CrossRefPubMed
18.
go back to reference Casparie M, Tiebosch AT, Burger G et al (2007) Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29(1):19–24PubMed Casparie M, Tiebosch AT, Burger G et al (2007) Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29(1):19–24PubMed
19.
go back to reference Belza B, Warms C (2004) Physical activity and exercise in women’s health. Nurs Clin North Am 39(1):181–193, viiiCrossRefPubMed Belza B, Warms C (2004) Physical activity and exercise in women’s health. Nurs Clin North Am 39(1):181–193, viiiCrossRefPubMed
20.
go back to reference Oguma Y, Sesso HD, Paffenbarger RS Jr, Lee IM (2002) Physical activity and all cause mortality in women: a review of the evidence. Br J Sports Med 36(3):162–172CrossRefPubMed Oguma Y, Sesso HD, Paffenbarger RS Jr, Lee IM (2002) Physical activity and all cause mortality in women: a review of the evidence. Br J Sports Med 36(3):162–172CrossRefPubMed
21.
go back to reference Kellen E, Vansant G, Christiaens MR, Neven P, Van Limbergen E (2009) Lifestyle changes and breast cancer prognosis: a review. Breast Cancer Res Treat 114(1):13–22CrossRefPubMed Kellen E, Vansant G, Christiaens MR, Neven P, Van Limbergen E (2009) Lifestyle changes and breast cancer prognosis: a review. Breast Cancer Res Treat 114(1):13–22CrossRefPubMed
22.
go back to reference Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293(20):2479–2486CrossRefPubMed Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293(20):2479–2486CrossRefPubMed
23.
go back to reference Friedenreich CM, Gregory J, Kopciuk KA, Mackey JR, Courneya KS (2009) Prospective cohort study of lifetime physical activity and breast cancer survival. Int J Cancer 124(8):1954–1962CrossRefPubMed Friedenreich CM, Gregory J, Kopciuk KA, Mackey JR, Courneya KS (2009) Prospective cohort study of lifetime physical activity and breast cancer survival. Int J Cancer 124(8):1954–1962CrossRefPubMed
24.
go back to reference Andrieu N, Easton DF, Chang-Claude J et al (2006) Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS collaborators’ group. J Clin Oncol 24(21):3361–3366CrossRefPubMed Andrieu N, Easton DF, Chang-Claude J et al (2006) Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS collaborators’ group. J Clin Oncol 24(21):3361–3366CrossRefPubMed
25.
go back to reference Brohet RM, Goldgar DE, Easton DF et al (2007) Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS collaborating group. J Clin Oncol 25(25):3831–3836CrossRefPubMed Brohet RM, Goldgar DE, Easton DF et al (2007) Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS collaborating group. J Clin Oncol 25(25):3831–3836CrossRefPubMed
26.
go back to reference Andrieu N, Goldgar DE, Easton DF et al (2006) Pregnancies, breast-feeding, and breast cancer risk in the international BRCA1/2 carrier cohort study (IBCCS). J Natl Cancer Inst 98(8):535–544PubMedCrossRef Andrieu N, Goldgar DE, Easton DF et al (2006) Pregnancies, breast-feeding, and breast cancer risk in the international BRCA1/2 carrier cohort study (IBCCS). J Natl Cancer Inst 98(8):535–544PubMedCrossRef
27.
go back to reference Ainsworth BE, Haskell WL, Leon AS et al (1993) Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25(1):71–80CrossRefPubMed Ainsworth BE, Haskell WL, Leon AS et al (1993) Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25(1):71–80CrossRefPubMed
28.
go back to reference Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32(9 Suppl):S498–S504PubMed Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32(9 Suppl):S498–S504PubMed
29.
go back to reference Antoniou AC, Goldgar DE, Andrieu N et al (2005) A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol 29(1):1–11CrossRefPubMed Antoniou AC, Goldgar DE, Andrieu N et al (2005) A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol 29(1):1–11CrossRefPubMed
30.
go back to reference Rubinstein WS (2008) Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics. Fam Cancer 7(1):83–89CrossRefPubMed Rubinstein WS (2008) Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics. Fam Cancer 7(1):83–89CrossRefPubMed
31.
go back to reference Silva E, Gatalica Z, Snyder C, Vranic S, Lynch JF, Lynch HT (2008) Hereditary breast cancer: part II. Management of hereditary breast cancer: implications of molecular genetics and pathology. Breast J 14(1):14–24CrossRefPubMed Silva E, Gatalica Z, Snyder C, Vranic S, Lynch JF, Lynch HT (2008) Hereditary breast cancer: part II. Management of hereditary breast cancer: implications of molecular genetics and pathology. Breast J 14(1):14–24CrossRefPubMed
32.
go back to reference Bermejo-Perez MJ, Marquez-Calderon S, Llanos-Mendez A (2007) Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: a systematic review. Int J Cancer 121(2):225–231CrossRefPubMed Bermejo-Perez MJ, Marquez-Calderon S, Llanos-Mendez A (2007) Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: a systematic review. Int J Cancer 121(2):225–231CrossRefPubMed
33.
go back to reference Hosey AM, Gorski JJ, Murray MM et al (2007) Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. J Natl Cancer Inst 99(22):1683–1694CrossRefPubMed Hosey AM, Gorski JJ, Murray MM et al (2007) Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. J Natl Cancer Inst 99(22):1683–1694CrossRefPubMed
34.
go back to reference Friedenreich CM, Orenstein MR (2002) Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 132(11 Suppl):3456S–3464SPubMed Friedenreich CM, Orenstein MR (2002) Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 132(11 Suppl):3456S–3464SPubMed
35.
36.
go back to reference Neilson HK, Friedenreich CM, Brockton NT, Millikan RC (2009) Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev 18(1):11–27CrossRefPubMed Neilson HK, Friedenreich CM, Brockton NT, Millikan RC (2009) Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev 18(1):11–27CrossRefPubMed
37.
go back to reference Friedenreich CM (2004) Physical activity and breast cancer risk: the effect of menopausal status. Exerc Sport Sci Rev 32(4):180–184CrossRefPubMed Friedenreich CM (2004) Physical activity and breast cancer risk: the effect of menopausal status. Exerc Sport Sci Rev 32(4):180–184CrossRefPubMed
38.
go back to reference Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591CrossRefPubMed Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591CrossRefPubMed
39.
go back to reference Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36(5):936–942PubMed Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36(5):936–942PubMed
40.
go back to reference Maruti SS, Willett WC, Feskanich D, Levine B, Rosner B, Colditz GA (2009) Physical activity and premenopausal breast cancer: an examination of recall and selection bias. Cancer Causes Control 20(5):549–558CrossRefPubMed Maruti SS, Willett WC, Feskanich D, Levine B, Rosner B, Colditz GA (2009) Physical activity and premenopausal breast cancer: an examination of recall and selection bias. Cancer Causes Control 20(5):549–558CrossRefPubMed
41.
go back to reference Falkner KL, Trevisan M, McCann SE (1999) Reliability of recall of physical activity in the distant past. Am J Epidemiol 150(2):195–205PubMed Falkner KL, Trevisan M, McCann SE (1999) Reliability of recall of physical activity in the distant past. Am J Epidemiol 150(2):195–205PubMed
Metadata
Title
Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers
Authors
Anouk Pijpe
Peggy Manders
Richard M. Brohet
J. Margriet Collée
Senno Verhoef
Hans F. A. Vasen
Nicoline Hoogerbrugge
Christi J. van Asperen
Charlotte Dommering
Margreet G. E. M. Ausems
Cora M. Aalfs
Encarna B. Gomez-Garcia
Laura J. van‘t Veer
Flora E. van Leeuwen
Matti A. Rookus
HEBON
Publication date
01-02-2010
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2010
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-009-0476-0

Other articles of this Issue 1/2010

Breast Cancer Research and Treatment 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine